A Review On Targeted Treatment Update On Ulcerative Colitis.
International Journal of Drug Delivery Technology · 02.06.2026 · 16 (43s)
DOI: 10.25258/ijddt.16.43s.81 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 02.06.2026. Verfasst von Samreen Ali und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Ulcerative colitis (UC) is a chronic, relapsing-remitting inflammatory bowel disease (IBD) that predominantly affects the colonic mucosa. The disease significantly impacts the quality of life of patients and presents a rising global health concern due to increasing prevalence, particularly in newly industrialized countries. Recent advances in understanding the pathophysiology of UC have led to the development of targeted therapies aimed at modulating specific immune pathways, minimizing systemic immunosuppression, and improving therapeutic outcomes. This review provides an updated overview of the etiology, epidemiology, and immunopathogenesis of UC, with a special focus on the recent developments in targeted treatments including biologics (anti-TNF, antiintegrins, anti-interleukins), small molecules (JAK inhibitors, S1P receptor modulators), and novel investigational therapies. The paper also evaluates their efficacy, safety profiles, mechanisms of action, and place in current clinical practice. Understanding these advances is essential for optimizing treatment strategies and improving patient outcomes in UC.
Zitieren
APA
Ali, S., & Upmanyu, N. (2026). A Review On Targeted Treatment Update On Ulcerative Colitis. International Journal of Drug Delivery Technology, 16(43s). https://doi.org/10.25258/ijddt.16.43s.81
Vancouver
Ali S, Upmanyu N. A Review On Targeted Treatment Update On Ulcerative Colitis. International Journal of Drug Delivery Technology. 2026;16(43s). doi:10.25258/ijddt.16.43s.81
BibTeX
@article{Ali2026,
author = {Ali, Samreen and Upmanyu, Neeraj},
title = {A Review On Targeted Treatment Update On Ulcerative Colitis},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {43s},
doi = {10.25258/ijddt.16.43s.81}
}
EUVIMED